Shimadzu
Japanese Consortium Launches Study to Evaluate Utility of Blood-Based Alzheimer's Markers
Shimadzu, Eisai, Oita University, and Usuki City Medical Association are studying the markers in 100 patients using Shimadzu's mass spec technology.
Shimadzu, Eisai, Oita University, and Usuki City Medical Association are studying the markers in 100 patients using Shimadzu's mass spec technology.